These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6327964)

  • 1. Potentiation of antitumor activity of 5-fluoro-2'-deoxyuridine by guanosine-5'-monophosphate.
    Iigo M; Hoshi A
    J Pharmacobiodyn; 1984 Jan; 7(1):67-9. PubMed ID: 6327964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of the chemotherapeutic action of 5'-deoxy-5-fluorouridine in combination with guanosine and related compounds.
    Iigo M; Miwa M; Ishitsuka H; Nitta K
    Cancer Chemother Pharmacol; 1987; 19(1):61-4. PubMed ID: 3028664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of molar ratio on the combination effect of 5-fluorouracil with guanosine 5'-monophosphate on P388 and L1210 leukemias.
    Iigo M; Hoshi A
    Eur J Cancer Clin Oncol; 1984 Mar; 20(3):411-5. PubMed ID: 6323189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of guanosine on antitumor activity of fluorinated pyrimidines against P 388 leukemia.
    Iigo M; Hoshi A
    Cancer Chemother Pharmacol; 1984; 13(2):86-90. PubMed ID: 6235977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of potentiation of antitumor activity of 5-fluoro-2'-deoxyuridine in the adenocarcinoma 755 system by guanosine 5'-monophosphate.
    Iigo M; Yamaizumi Z; Nakajima Y; Nishimura S; Hoshi A
    Drugs Exp Clin Res; 1988; 14(4):257-63. PubMed ID: 2458897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation by acyclothymidine esters of the antitumor effect of orally administered 5-fluoro-2'-deoxyuridine esters on L1210 in mice.
    Kawaguchi T; Saito M; Saneyoshi M
    Jpn J Cancer Res; 1986 May; 77(5):436-9. PubMed ID: 2942523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo antitumor effects of fluoropyrimidines on colon adenocarcinoma 38 and enhancement by leucovorin.
    Iigo M; Nishikata K; Hoshi A
    Jpn J Cancer Res; 1992 Apr; 83(4):392-6. PubMed ID: 1387127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of antitumor activity of 5-fluorouracil by ribothymidine.
    Tezuka M; Chiba Y; Okada S; Tamemasa O
    J Pharmacobiodyn; 1986 Aug; 9(8):683-7. PubMed ID: 3783412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of the antitumor effect of 5-fluoro-2'-deoxyuridine esters in combination with acyclothymidine esters on L1210 in mice via oral administration.
    Kawaguchi T; Saito M; Saneyoshi M
    J Pharm Sci; 1988 Nov; 77(11):939-43. PubMed ID: 2976090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled release of 5-fluoro-2'-deoxyuridine by the combination of prodrug and polymer matrix.
    Endoh H; Kawaguchi T; Seki T; Hasegawa T; Juni K
    Chem Pharm Bull (Tokyo); 1991 Feb; 39(2):458-64. PubMed ID: 1829027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Fluorouracil and derivatives in cancer chemotherapy. 3. In vivo enhancement of antitumor activity of 5-fluorouracil (FU) and 5-fluoro-2'-deoxyuridine (FUDR).
    Jato J; Windheuser JJ
    J Pharm Sci; 1973 Dec; 62(12):1975-8. PubMed ID: 4271579
    [No Abstract]   [Full Text] [Related]  

  • 12. Potentiation of the chemotherapeutic effect of 5-fluorouracil by combination with guanosine 5'-monophosphate.
    Iigo M; Nakajima Y; Kuretani K; Hoshi A
    Gan; 1983 Apr; 74(2):291-8. PubMed ID: 6305753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Synergism of sobuzoxane in combination with doxorubicin against leukemia P388 in mice].
    Dai ZQ; Xu JY; Yuan XJ; Cai JC
    Zhongguo Yao Li Xue Bao; 1996 Jan; 17(1):69-71. PubMed ID: 8737460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of antitumor activity of pirarubicin by chlorpromazine in mice bearing doxorubicin-resistant P388 leukemia.
    Shibata H; Maekawa I; Furusawa S; Kawauchi H; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1990 Dec; 70(3):359-62. PubMed ID: 2093213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of deoxyuridine coadministration on toxicity and antitumor activity of fluorouracil and floxuridine.
    Jato JG; Lake LM; Grunden EE; Johnson BM
    J Pharm Sci; 1975 Jun; 64(6):943-6. PubMed ID: 124347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of alkylesters of 5-fluoro-2'-deoxyuridine 5'-monophosphate (FdUMP) against murine lymphoma L5178Y resistant to 5-fluoro-2'-deoxyuridine.
    Kanzawa F; Matsushima Y; Ishihara J; Hoshi A; Ohba T; Watanabe K
    J Pharmacobiodyn; 1986 Aug; 9(8):688-93. PubMed ID: 2946859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effects of pirarubicin and epirubicin in combination with doxifluridine and cisplatin against mouse P388 leukemia.
    Agata N; Mase T; Izumi H; Hirano S; Iguchi H; Tone H; Takeuchi T
    Cancer Biochem Biophys; 1995 Nov; 15(2):95-101. PubMed ID: 8590441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of 3',5'-diesters of 5-fluoro-2'-deoxyuridine against murine leukemia L1210 cells.
    Kanzawa F; Hoshi A; Kuretani K; Saneyoshi M; Kawaguchi T
    Cancer Chemother Pharmacol; 1981; 6(1):19-23. PubMed ID: 6456083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination effects of Ara-C and 5-fluorodeoxyuridine against leukemia cells in vitro and in mice.
    Rauko P; Bauer W; Horvath Z; Höchtl T; Saiko P; Karl D; Schott H; Fritzer-Szekeres M; Novotny L; Szekeres T
    Anticancer Res; 2003; 23(5A):3841-6. PubMed ID: 14666686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation by dipyridamole of 5-fluorouridine antitumor activity against a rat adenocarcinoma in vivo.
    el Hag IA; Roos G; Jönsson PE; Stenram U
    Anticancer Res; 1990; 10(1):29-32. PubMed ID: 2139770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.